This sets out proposed new care models for glaucoma patients in order to better utilise primary care capacity, while still maintaining patient safety.
Glaucoma is the second leading cause of irreversible sight loss in the UK and affects over one million people, which is predicted to rise by 100,000 cases to 1.145 million people by 2030*.
In each issue, Acuity poses a topical question on a tricky scenario to a panel of members.
Clinical files: What impact should a patient's home genetics test have on my clinical decision-making?
Read the guidance on examining patients at risk from glaucoma
This member briefing covers the guideline on Glaucoma: diagnosis and management
Find out more about getting a College-accredited higher qualification in glaucoma.
More information for patients on glaucoma, including a directory to find their nearest optometrist member.
A College-accredited higher qualification will equip you for new challenges and responsibilities, and support your continuing professional development and career progression.
Member briefing: The revised NICE guideline Glaucoma: diagnosis and management came into effect on 1 November 2017. The member briefing below summarises the main points and outlines how it will affect you in practice.
This year’s Optometry Tomorrow programme is designed to help you grow the skills that make the biggest difference in practice.
Chris Steele FCOptom, Clinical Editor of Acuity, wants to make 2026 smarter and leaner
Eye health issues that are making the news.
A glance at what’s happening in the world of technology.
How does selective laser trabeculoplasty work and how do patients experience the procedure? Becky McCall reports.
A bill introduced by Shockat Adam MP proposes a nationally consistent, optometry-led glaucoma testing service in England to shift care from hospitals to community practices.
The clinical figures that count.